[GSK484, a PAD4 inhibitor, improves endothelial dysfunction in mice with sepsis-induced lung injury by inhibiting H3Cit expression].

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-12-20
DOI
https://doi.org/10.12122/j.issn.1673-4254.2024.12.16
Citations
1
Primary Topic
Inflammation biomarkers and pathways
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[GSK484, a PAD4 inhibitor, improves endothelial dysfunction in mice with sepsis-induced lung injury by inhibiting H3Cit expression].

Ziqi Jin, Bin Liu, Lian Li, Xiaofei Su et al.
1 citations
PubMed
Inflammation biomarkers and pathways
article

[GSK484, a PAD4 inhibitor, improves endothelial dysfunction in mice with sepsis-induced lung injury by inhibiting H3Cit expression].

Ziqi Jin, Bin Liu, Lian Li, Xiaofei Su, Jian Dai, Bao Guo Xiao
article en
1 citations

Abstract

No abstract available for this paper.
PubMedVol. 44(12)
Central South University (CN), The First Hospital of Changsha (CN), Xiangya Hospital Central South University (CN)
Inflammation biomarkers and pathways
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.